Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013000 · ClinicalTrials.gov registry record · NA

A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines

A NA study of Schizophrenia, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
400
Enrollment target
6
Study locations

NCT00013000 is a NA study of Schizophrenia that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 400 participants, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (83% higher). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013000, a NA study of Schizophrenia, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target
6
Study locations

Study Summary

Schizophrenia, a chronic psychiatric disorder, is the second most frequent VA discharge diagnosis. Medication management practices for schizophrenia often are not guideline-concordant and place patients at risk for adverse outcomes. This project tests a new strategy to standard implementation for VHA Schizophrenia Guidelines.

Conditions Studied

Interventions

  • BEHAVIORAL Test strategy for implementation guideline

Study Locations (6)

Texas

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
  • Michael E. DeBakey VA Medical Center, Houston, TX - Houston
  • South Texas Health Care System, San Antonio, TX - San Antonio

District of Columbia

  • Washington DC VA Medical Center, Washington, DC - Washington D.C.

Louisiana

  • Southeast Louisiana Veterans Health Care System, New Orleans, LA - New Orleans

Maryland

  • Tuscaloosa VA Medical Center, Tuscaloosa, AL - Tuscaloosa

Trial Details

FieldValue
Enrollment Target 400 participants
Est. Completion 2000-09
Phase NA

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00013000

The ClinicalTrials.gov registry entry for NCT00013000 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (83% higher). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Test strategy for implementation guideline is the first listed.

NCT00013000 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Texas, District of Columbia, Louisiana.

Frequently Asked Questions

What is clinical trial NCT00013000 about?

NCT00013000 is a clinical study titled "A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines". Schizophrenia, a chronic psychiatric disorder, is the second most frequent VA discharge diagnosis. Medication management practices for schizophrenia often are not guideline-concordant and place patients at risk for adverse outcomes. This project tests a new strategy to standard implementation for VH...

What is the current status of trial NCT00013000?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. Estimated completion is 2000-09.

What conditions does trial NCT00013000 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT00013000?

The interventions under investigation include: Test strategy for implementation guideline (BEHAVIORAL).

Who is sponsoring clinical trial NCT00013000?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00013000 being conducted?

This trial has 6 study locations across District of Columbia, Louisiana, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.